Phake
The Deadly World of Falsified and Substandard Medicines
Published on 30. January 2014
Book
Hardback
400 pages
978-0-8447-7232-5 (ISBN)
Description
Roger Bate has spent years on the trail of counterfeit medicines in Asia, Africa, and the Middle East, learning the anatomy of a nebulous, far-reaching black market that has resulted in countless deaths and injuries around the world. Phake: The Deadly World of Falsified and Substandard Medicines is the culmination of Bate's research and travels-both a fascinating firsthand account of the counterfeit drug trade and an incisive policy analysis with important ramifications for decision makers in the U.S. Food and Drug Administration and the international World Health Organization.
Reviews / Votes
Economist Bate (fellow, American Enterprise Inst.) here expands on his brief 2008 book, Making a Killing: The Deadly Implications of the Counterfeit Drug Trade. For this work, he traveled the world, investigating drugs that were less potent than they should have been (and therefore less likely to be effective), adulterated with agents ranging from talc to toxins, made available for purchase past their expiration date, and-the major focus-falsified, intentionally mislabeled, or counterfeit and intended to mislead the purchaser (as in the case of Viagra). Bate is attentive to the problem of fake drugs sold over the Internet, and his experiences online as well as his personal connections with government officials highlight his deep interest in and knowledge of the subject. Bate outlines the fake drug situation in Asia, the Middle East, Russia, and Turkey, among other places, but devotes the most attention to the "phake" industry in Nigeria, India, and China. VERDICT No scientific knowledge is necessary to understand and appreciate the problems that Bate addresses. Anyone concerned about the quality of prescription medications will find this book of interest. Library Journal Bate's work is more than a detailed analysis; it is also a revelatory first-hand account of the counterfeit drug trade ForbesMore details
Language
English
Place of publication
Washington DC
United States
Illustrations
col. Illustrations, col. maps
Dimensions
Height: 235 mm
Width: 162 mm
Thickness: 31 mm
Weight
1066 gr
ISBN-13
978-0-8447-7232-5 (9780844772325)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Person
Roger Bate is a visiting scholar at the American Enterprise Institute in Washington, D.C. He has spent years on the trail of stolen counterfeit and substandard medicines in Asia, Africa, and the Middle East, learning the anatomy of the nebulous, far-reaching black market that has caused countless deaths and injuries around the world. He has undertaken field research on fake medicines using handheld spectrometers and laboratory research using basic and sophisticated techniques. He has studied the laws and economics affecting the medicine trade and has published widely in the peer-reviewed scientific, legal and economic literature, including in leading journals such as The Lancet, The Journal of Health Economics, the Journal of International Criminal Justice and the Malaria Journal. He has published nearly one hundred articles on the topic in popular media outlets including the New York Times, the Washington Post and the Wall Street Journal. Take a look at the author's blog here.
Content
Preface Introduction Part I: The Deadly World of Dangerous Medicines 1.Historical Examples of Dangerous Medicines 2.Understanding the Problem 3.Overview of Research Findings and Possible Solutions Part II: Dangerous Drug Problems by Location 4.Africa 5.India 6.China 7.Middle East 8.Other Emerging Markets 9.Russia 10.Latin America 11.Thailand 12.Turkey 13.The Online Drug Market Part III: Drug-Quality Assessments 14.Factors to Consider for Research 15.Results: What We Found 16.Results Broken Out for Africa, India, and Other Markets 17.Interpreting the Results Part IV: The Way Forward 18.Developing Medical Regulatory Authorities: The U.S. FDA as Case Study 19.International Cooperation against Criminals and the Lethal Trade in Fake Medicines 20.Market for Products of Varying Quality and the Intellectual Property Debate 21.Conclusion Part V: Appendices Appendix A: Peer-Reviewed Publications and Working Papers Appendix B: Research Methods Appendix C: Accessing Online Components of This Book